- About Us
- Our Clients
- Our Expertise
- Our People
- Global Services
- Contact Us
05 October 2010
Hector MacKay-Dunn, who has been actively advocating for the extension of the flow-through shares to the biotech industry for over a decade, commented on the industry’s recent government lobbying for the model in the September 28 – October 4 issue of Business in Vancouver.
Flow-through shares allow companies with little or no taxable income to pass on tax deductions to investor. They have been available to mining companies for many years and are largely used in the exploration phase.
Mr MacKay-Dunn is a committee member of BIOTECanada, the national industry organization representing biotechnology companies as well as a long standing board member of LifeSciences British Columbia. A noted corporate lawyer he represents companies across many sectors including the biotech and resource industries.
To read the article please click here.
For Mr. MacKay-Dunn’s biography please click here.
Sign up for our Email Newsletter to receive regular Farris updates: